Stock Movers: Eli Lilly, Fortinet, Airbnb, DoorDash Market Updates

Eli Lilly's Weight Loss Pill Study

• 📉 Eli Lilly shares are down approximately 14% following the release of their latest weight loss pill study results.
• 💡 The experimental pill, orforglipron, helped patients shed about 11% of their body weight, which fell short of Wall Street expectations.
• 🎯 By comparison, Novo Nordisk's Wegovy resulted in a weight loss of about 14-15%.
• 💰 Despite the study results, Eli Lilly's full-year revenue forecast did come in higher than expected.

Fortinet's Software Refresh Cycle

• ⚠️ Fortinet experienced a significant drop of about 21% in pre-market trading after an update on its firewall refresh cycle.
• 📉 Analysts have issued downgrades, citing that the product refresh cycle is now expected to be a much smaller catalyst than previously anticipated.
• 📊 This news has tempered the momentum and hope built into the stock.

Airbnb's Third Quarter Outlook

• 📊 Airbnb shares fell about 6.5% after releasing its third-quarter outlook.
• ⚠️ While third-quarter revenue was in line with estimates, the company warned that macroeconomic uncertainty may be overshadowing its financial performance.
• 📈 Growth rates are expected to remain relatively stable, similar to the 7.4% achieved in the second quarter, but tougher year-over-year comparisons are anticipated later in the year.

DoorDash's Strong Order Outlook

• 🚀 DoorDash shares are up over 8% due to a strong outlook for third-quarter orders, surpassing Wall Street expectations.
• 💰 The company projects a gross order value range of $24.2 billion to $24.7 billion.
• ✅ This positive outlook is attributed to a growing number of active customers and increased engagement, with high levels of consumer engagement in the U.S.
• 📈 DoorDash also reported beating average estimates for delivery orders, hitting a company record.